Hill AV - Search Results

1

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.

Lillie PJ, Berthoud TK, Powell TJ, Lambe T, Mullarkey C, Spencer AJ, Hamill M, Peng Y, Blais ME, Duncan CJ, Sheehy SH, Havelock T, Faust SN, Williams RL, Gilbert A, Oxford J, Dong T, Hill AV, Gilbert SC. Lillie PJ, et al. Among authors: hill av. Clin Infect Dis. 2012 Jul;55(1):19-25. doi: 10.1093/cid/cis327. Epub 2012 Mar 22. Clin Infect Dis. 2012. PMID: 22441650 Free PMC article. Clinical Trial.

2

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.

Gilbert SC, Schneider J, Hannan CM, Hu JT, Plebanski M, Sinden R, Hill AV. Gilbert SC, et al. Among authors: hill av. Vaccine. 2002 Jan 15;20(7-8):1039-45. doi: 10.1016/s0264-410x(01)00450-9. Vaccine. 2002. PMID: 11803063

3

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

McConkey SJ, Reece WH, Moorthy VS, Webster D, Dunachie S, Butcher G, Vuola JM, Blanchard TJ, Gothard P, Watkins K, Hannan CM, Everaere S, Brown K, Kester KE, Cummings J, Williams J, Heppner DG, Pathan A, Flanagan K, Arulanantham N, Roberts MT, Roy M, Smith GL, Schneider J, Peto T, Sinden RE, Gilbert SC, Hill AV. McConkey SJ, et al. Among authors: hill av. Nat Med. 2003 Jun;9(6):729-35. doi: 10.1038/nm881. Epub 2003 May 25. Nat Med. 2003. PMID: 12766765 Clinical Trial.

4

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.

Moorthy VS, Pinder M, Reece WH, Watkins K, Atabani S, Hannan C, Bojang K, McAdam KP, Schneider J, Gilbert S, Hill AV. Moorthy VS, et al. Among authors: hill av. J Infect Dis. 2003 Oct 15;188(8):1239-44. doi: 10.1086/378515. Epub 2003 Sep 30. J Infect Dis. 2003. PMID: 14551895 Clinical Trial.

5

Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses.

Taracha EL, Bishop R, Musoke AJ, Hill AV, Gilbert SC. Taracha EL, et al. Among authors: hill av. Infect Immun. 2003 Dec;71(12):6906-14. doi: 10.1128/IAI.71.12.6906-6914.2003. Infect Immun. 2003. PMID: 14638779 Free PMC article.

6

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.

Prieur E, Gilbert SC, Schneider J, Moore AC, Sheu EG, Goonetilleke N, Robson KJ, Hill AV. Prieur E, et al. Among authors: hill av. Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):290-5. doi: 10.1073/pnas.0307158101. Epub 2003 Dec 23. Proc Natl Acad Sci U S A. 2004. PMID: 14694197 Free PMC article.

7

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus.

Anderson RJ, Hannan CM, Gilbert SC, Laidlaw SM, Sheu EG, Korten S, Sinden R, Butcher GA, Skinner MA, Hill AV. Anderson RJ, et al. Among authors: hill av. J Immunol. 2004 Mar 1;172(5):3094-100. doi: 10.4049/jimmunol.172.5.3094. J Immunol. 2004. PMID: 14978115

8

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.

Moorthy VS, Imoukhuede EB, Keating S, Pinder M, Webster D, Skinner MA, Gilbert SC, Walraven G, Hill AV. Moorthy VS, et al. Among authors: hill av. J Infect Dis. 2004 Jun 15;189(12):2213-9. doi: 10.1086/421118. Epub 2004 May 24. J Infect Dis. 2004. PMID: 15181568 Clinical Trial.

9

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin.

Vordermeier HM, Rhodes SG, Dean G, Goonetilleke N, Huygen K, Hill AV, Hewinson RG, Gilbert SC. Vordermeier HM, et al. Among authors: hill av. Immunology. 2004 Jul;112(3):461-70. doi: 10.1111/j.1365-2567.2004.01903.x. Immunology. 2004. PMID: 15196215 Free PMC article.

10

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.

Behboudi S, Moore A, Gilbert SC, Nicoll CL, Hill AV. Behboudi S, et al. Among authors: hill av. Vaccine. 2004 Oct 22;22(31-32):4326-31. doi: 10.1016/j.vaccine.2004.04.029. Vaccine. 2004. PMID: 15474725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

831 results

Search Page